Smoking and age-related macular degeneration: Review and update

Journal of Ophthalmology

Volumn 2013, Issue , 2013, Pages

  Velilla, Sara ^a,b   García Medina, José Javier ^c,d,e   García Layana, Alfredo ^b,f   Dolz Marco, Rosa ^e,g   Pons Vázquez, Sheila ^e   Pinazo Durán, M Dolores ^b,e,h   Gómez Ulla, Francisco ^b,i,j   Arévalo, J Fernando ^k,l   Díaz Llopis, Manuel ^b,g,h   Gallego Pinazo, Roberto ^b,e,g  

^a HOSPITAL SAN PEDRO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF MURCIA   (Spain)

^e UNIVERSITY OF VALENCIA   (Spain)

^f UNIVERSITY CLINIC OF NAVARRA   (Spain)

^g HOSPITAL UNIVERSITARIO LA FE   (Spain)

^h UNIVERSITY OF VALENCIA   (Spain)

ⁱ Ophthalmologic Institute Gomez Ulla   (Spain)

^j UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^k JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l KING KHALED EYE SPECIALIST HOSPITAL   (Saudi Arabia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893827125     PISSN: 2090004X     EISSN: 20900058     Source Type: Journal    
DOI: 10.1155/2013/895147     Document Type: Review

References (108)

1. Attebo K., Mitchell P., Smith W., Visual acuity and the causes of visual loss in Australia: the Blue Mountains Eye Study. Ophthalmology 1996 103 3 357 364 2-s2.0-0030003687 (Pubitemid 26085889)
2. Maguire M. G., Bressler S. B., Bresskr N. M., Alexander J., Hiner C. J., Javomik N. B., Phillips D., Marsh M., Haivfeins B. S., Burgess D. B., Chandra S., Klein M. L., David H., Stevens T., Fine S. L., Hawhins B. S., Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Archives of Ophthalmology 1997 115 6 741 747 2-s2.0-8544234955 (Pubitemid 27276256)
3. Klaver C. C. W., Wolfs R. C. W., Vingerling J. R., Hofman A., De Jong P. T. V. M., Age-specific prevalence and causes of blindness and visual impairment in an older population: the Rotterdam study. Archives of Ophthalmology 1998 116 5 653 658 2-s2.0-0031695623 (Pubitemid 28414581)
4. Casten R. J., Rovner B. W., Tasman W., Age-related macular degeneration and depression: a review of recent research. Current Opinion in Ophthalmology 2004 15 3 181 183 2-s2.0-2442545564 10.1097/01.icu.0000120710.35941.3f (Pubitemid 38638861)
5. Friedman D. S., O'Colmain B. J., Muñoz B., Tomany S. C., McCarty C., DeJong P. T. V. M., Nemesure B., Mitchell P., Kempen J., Congdon N., Prevalence of age-related macular degeneration in the United States. Archives of Ophthalmology 2004 122 4 564 572 2-s2.0-11144354339 10.1001/archopht.122.4.564 (Pubitemid 38456293)
6. Lotery A., Xu X., Zlatava G., Loftus J., Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study. British Journal of Ophthalmology 2007 91 10 1303 1307 2-s2.0-34848904518 10.1136/bjo.2007.116939 (Pubitemid 47492861)
7. Jager R. D., Mieler W. F., Miller J. W., Age-related macular degeneration. New England Journal of Medicine 2006 358 2606 2617
8. Gallego-Pinazo R., Dolz-Marco R., Díaz-Llopis M., Towards the new spectral-domain optical coherence tomography based classification of age-related macular degeneration. Archivos de la Sociedad Española de Oftalmología 2012 87 8 247 252
9. Klein R., Klein B. E. K., Jensen S. C., Meuer S. M., The five-year incidence and progression of age-related maculopathy: the beaver dam eye study. Ophthalmology 1997 104 1 7 21 2-s2.0-0031056911 (Pubitemid 27081937)
10. Seddon J. M., Schachat A. P., Ryan S., Epidemiology of age-related macular degeneration. Retina 2001 3rd St. Louis, Mo, USA Mosby 1039 1050
11. Chakravarthy U., Wong T. Y., Fletcher A., Piault E., Evans C., Zlateva G., Buggage R., Pleil A., Mitchell P., Clinical risk factors for age-related macular degeneration: a systematic review and meta-analysis. BMC Ophthalmology 2010 10 1, article 31 2-s2.0-78649936436 10.1186/1471-2415-10-31
12. Klein R., Peto T., Bird A., Vannewkirk M. R., The epidemiology of age-related macular degeneration. American Journal of Ophthalmology 2004 137 3 486 495 2-s2.0-1542297335 10.1016/j.ajo.2003.11.069 (Pubitemid 38328641)
13. Seddon J. M., Sobrin L., Albert D., Miller J., Azar D., Blodi B., Epidemiology of age-related macular degeneration. Albert and Jakobiec's Principles and Practice of Ophthalmology 2008 1 3rd Philadelphia, Pa, USA Saunders 413 422
14. de Jong P. T. V. M., Age-related macular degeneration. New England Journal of Medicine 2006 355 14 1474 1485 2-s2.0-33749440219 10.1056/NEJMra062326 (Pubitemid 44511562)
15. Seddon J. M., Ajani U. A., Sperduto R. D., Hiller R., Blair N., Burton T. C., Farber M. D., Gragoudas E. S., Haller J., Miller D. T., Yannuzzi L. A., Willett W., Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Journal of the American Medical Association 1994 272 18 1413 1420 2-s2.0-0027946498 10.1001/jama.272.18.1413 (Pubitemid 24328383)
16. Seddon J. M., Willett W. C., Speizer F. E., Hankinson S. E., A prospective study of cigarette smoking and age-related macular degeneration in women. Journal of the American Medical Association 1996 276 14 1141 1146 2-s2.0-0029758899 10.1001/jama.276.14.1141 (Pubitemid 26329740)
17. Seddon J. M., Cote J., Davis N., Rosner B., Progression of age-related macular degeneration: association with body mass index, waist circumference, and waist-hip ratio. Archives of Ophthalmology 2003 121 6 785 792 2-s2.0-0038010714 10.1001/archopht.121.6.785 (Pubitemid 36676214)
18. Seddon J. M., Cote J., Rosner B., Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. Archives of Ophthalmology 2003 121 12 1728 1737 2-s2.0-0344305692 10.1001/archopht.121.12.1728 (Pubitemid 37517440)
19. Seddon J. M., Rosner B., Sperduto R. D., Yannuzzi L., Haller J. A., Blair N. P., Willett W., Dietary fat and risk for advanced age-related macular degeneration. Archives of Ophthalmology 2001 119 8 1191 1199 2-s2.0-0034899733 (Pubitemid 32730008)
20. Klein R., Klein B. E. K., Linton K. L. P., Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992 99 6 933 943 2-s2.0-0026681119
21. Vingerling J. R., Dielemans I., Hofman A., Grobbee D. E., Hijmering M., Kramer C. F. L., De Jong P. T. V. M., The prevalence of age-related maculopathy in the Rotterdam study. Ophthalmology 1995 102 2 205 210 2-s2.0-0028839002
22. Mitchell P., Smith W., Attebo K., Jie Jin Wang J. J. W., Prevalence of age-related maculopathy in Australia: the blue mountains eye study. Ophthalmology 1995 102 10 1450 1460 2-s2.0-0028843796
23. Tomany S. C., Wang J. J., Van Leeuwen R., Klein R., Mitchell P., Vingerling J. R., Klein B. E. K., Smith W., De Jong P. T. V. M., Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004 111 7 1280 1287 2-s2.0-3042662037 10.1016/j.ophtha.2003.11.010 (Pubitemid 38844822)
24. Klein R., Klein B. E. K., Linton K. L. P., DeMets D. L., The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. American Journal of Epidemiology 1993 137 2 190 200 2-s2.0-0027450026 (Pubitemid 23083671)
25. Klein R., Cruickshanks K. J., Nash S. D., Krantz E. M., Nieto F. J., Huang G. H., Pankow J. S., Klein B. E. K., The prevalence of age-related macular degeneration and associated risk factors. Archives of Ophthalmology 2010 128 6 750 758 2-s2.0-77953637555 10.1001/archophthalmol.2010.92
26. Vingerling J. R., Hofman A., Grobbee D. E., De Jong P. T. V. M., Age-related macular degeneration and smoking: the Rotterdam study. Archives of Ophthalmology 1996 114 10 1193 1196 2-s2.0-0029836759 (Pubitemid 26338849)
27. Smith W., Mitchell P., Leeder S. R., Smoking and age-related maculopathy: the blue mountains eye study. Archives of Ophthalmology 1996 114 12 1518 1523 2-s2.0-0029949607 (Pubitemid 26406270)
28. Mitchell P., Chapman S., Smith W., Smoking is a major cause of blindness. Medical Journal of Australia 1999 171 4 173 174 2-s2.0-0033575685
29. McCarty C. A., Mukesh B. N., Fu C. L., Mitchell P., Jie Jin Wang J. J. W., Taylor H. R., Risk factors for age-related maculopathy: the visual impairment project. Archives of Ophthalmology 2001 119 10 1455 1462 2-s2.0-0034800657 (Pubitemid 32963248)
30. Smith W., Assink J., Klein R., Mitchell P., Klaver C. C. W., Klein B. E. K., Hofman A., Jensen S., Wang J. J., De Jong P. T. V. M., Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001 108 4 697 704 2-s2.0-0035078715 10.1016/S0161-6420(00)00580-7 (Pubitemid 32238465)
31. Ardourel J. E., Risk factors associated with age-related macular degeneration: a case-control study in the Age-Related Eye Disease Study: age-related eye disease Study report number 3. Ophthalmology 2000 107 12 2224 2232 2-s2.0-0033652453 10.1016/S0161-6420(00)00409-7
32. Risk factors for neovascular age-related macular degeneration. The Eye Disease Case-Control Study Group. Archives of Ophthalmology 1992 110 1701 1708
33. Delcourt C., Diaz J.-L., Ponton-Sanchez A., Papoz L., Smoking and age-related macular degeneration: the POLA study. Archives of Ophthalmology 1998 116 8 1031 1035 2-s2.0-0032467373 (Pubitemid 29101827)
34. Moon B. G., Joe S. G., Hwang J. U., Kim H. K., Choe J., Yoon Y. H., Prevalence and risk factors of early-stage age-related macular degeneration in patients examined at a health promotion center in Korea. Journal of Korean Medical Science 2012 27 537 541
35. Cackett P., Yeo I., Cheung C. M. G., Vithana E. N., Wong D., Tay W. T., Tai E. S., Aung T., Wong T. Y., Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons. Ophthalmology 2011 118 5 846 852 2-s2.0-79955621859 10.1016/j.ophtha.2010.09.026
36. Klein R., Klein B. E. K., Moss S. E., Relation of smoking to the incidence of age-related maculopathy. The beaver dam eye study. American Journal of Epidemiology 1998 147 2 103 110 2-s2.0-0032518733 (Pubitemid 28060479)
37. Klein R., Klein B. E. K., Tomany S. C., Moss S. E., Ten-year incidence of age-related maculopathy and smoking and drinking: the Beaver Dam Eye Study. American Journal of Epidemiology 2002 156 7 589 598 2-s2.0-0036786670 10.1093/aje/kwf092
38. Mitchell P., Jin Wang J., Smith W., Leeder S. R., Smoking and the 5-year incidence of age-related maculopathy: the Blue Mountains Eye Study. Archives of Ophthalmology 2002 120 10 1357 1363 2-s2.0-0036822469 (Pubitemid 36105441)
39. Tan J. S. L., Mitchell P., Kifley A., Flood V., Smith W., Jie J. W., Smoking and the long-term incidence of age-related macular degeneration: the blue mountains eye study. Archives of Ophthalmology 2007 125 8 1089 1095 2-s2.0-34547905338 10.1001/archopht.125.8.1089 (Pubitemid 47258039)
40. Christen W. G., Glynn R. J., Manson J. E., Ajani U. A., Buring J. E., A prospective study of cigarette smoking and risk of age-related macular degeneration in men. Journal of the American Medical Association 1996 276 14 1147 1151 2-s2.0-0029759549 10.1001/jama.276.14.1147 (Pubitemid 26329741)
41. Milton R. C., Clemons T. E., Klien R., Seddon J. M., Ferris F. L. III, Risk factors for the incidence of advanced age-related macular degeneration in the Age-Related Eye Disease Study (AREDS): AREDS report no. 19. Ophthalmology 2005 112 4 533 539 2-s2.0-16244368037 10.1016/j.ophtha.2004.10.047
42. Coleman A. L., Seitzman R. L., Cummings S. R., Yu F., Cauley J. A., Ensrud K. E., Stone K. L., Hochberg M. C., Pedula K. L., Thomas E. L., Mangione C. M., The association of smoking and alcohol use with age-related macular degeneration in the oldest old. The Study of Osteoporotic Fractures. American Journal of Ophthalmology 2010 149 1 160 169 2-s2.0-72149089012 10.1016/j.ajo.2009.07.025
43. Cong R., Zhou B., Sun Q., Gu H., Tang N., Wang B., Smoking and the risk of age-related macular degeneration: a meta-analysis. Annals of Epidemiology 2008 18 8 647 656 2-s2.0-47349133166 10.1016/j.annepidem.2008.04.002 (Pubitemid 352001387)
44. Tamakoshi A., Yuzawa M., Matsui M., Uyama M., Fujiwara N. K., Ohno Y., Smoking and neovascular form of age related macular degeneration in late middle aged males: findings from a case-control study in Japan. British Journal of Ophthalmology 1997 81 10 901 904 2-s2.0-0030729197 (Pubitemid 27469975)
45. Fowles J., Dybing E., Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tobacco Control 2003 12 4 424 430 2-s2.0-4143062086 10.1136/tc.12.4.424 (Pubitemid 39452045)
46. Roth F., Bindewald A., Holz F. G., Keypathophysiologic pathways in age-related macular disease. Graefe's Archive for Clinical and Experimental Ophthalmology 2004 242 8 710 716 2-s2.0-4544273293 10.1007/s00417-004-0976-x (Pubitemid 39242849)
47. Benowitz N. L., Cigarette smoking and cardiovascular disease: pathophysiology and implications for treatment. Progress in Cardiovascular Diseases 2003 46 1 91 111 2-s2.0-0041967223 10.1016/S0033-0620(03)00087-2 (Pubitemid 37013221)
48. Heeschen C., Jang J. J., Weis M., Pathak A., Kaji S., Hu R. S., Tsao P. S., Johnson F. L., Cooke J. P., Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis. Nature Medicine 2001 7 7 833 839 2-s2.0-0034922748 10.1038/89961 (Pubitemid 32691639)
49. Heeschen C., Chang E., Aicher A., Cooke J. P., Endothelial progenitor cells participate in nicotine-mediated angiogenesis. Journal of the American College of Cardiology 2006 48 12 2553 2560 2-s2.0-33845316758 10.1016/j.jacc.2006.07.066 (Pubitemid 44881229)
50. Yu M., Liu Q., Sun J., Yi K., Wu L., Tan X., Nicotine improves the functional activity of late endothelial progenitor cells via nicotinic acetylcholine receptors. Biochemistry and Cell Biology 2011 89 4 405 410 2-s2.0-80051504917 10.1139/o11-032
51. Kiuchi K., Matsuoka M., Wu J. C., Silva R. L. E., Kengatharan M., Verghese M., Ueno S., Yokoi K., Khu N. H., Cooke J. P., Campochiaro P. A., Mecamylamine suppresses basal and nicotine-stimulated choroidal neovascularization. Investigative Ophthalmology and Visual Science 2008 49 4 1705 1711 2-s2.0-45549103174 10.1167/iovs.07-0089
52. Zhu B.-Q., Parmley W. W., Hemodynamic and vascular effects of active and passive smoking. American Heart Journal 1995 130 6 1270 1275 2-s2.0-0028841762 10.1016/0002-8703(95)90154-X
53. Brogan A. P., Dickerson T. J., Boldt G. E., Janda K. D., Altered retinoid homeostasis catalyzed by a nicotine metabolite: implications in macular degeneration and normal development. Proceedings of the National Academy of Sciences of the United States of America 2005 102 30 10433 10438 2-s2.0-23044447167 10.1073/pnas.0504721102 (Pubitemid 41061571)
54. Hoffman E. C., Reyes H., Chu F.-F., Sander F., Conley L. H., Brooks B. A., Hankinson O., Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991 252 5008 954 958 2-s2.0-0025906014 (Pubitemid 21917012)
55. Reyes H., Reisz-Porszasz S., Hankinson O., Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 1992 256 5060 1193 1195 2-s2.0-0026625037
56. Takeuchi A., Takeuchi M., Oikawa K., Sonoda K.-H., Usui Y., Okunuki Y., Takeda A., Oshima Y., Yoshida K., Usui M., Goto H., Kuroda M., Effects of dioxin on vascular endothelial growth factor (VEGF) production in the retina associated with choroidal neovascularization. Investigative Ophthalmology and Visual Science 2009 50 7 3410 3416 2-s2.0-67649946260 10.1167/iovs.08-2299
57. Beatty S., Koh H.-H., Phil M., Henson D., Boulton M., The role of oxidative stress in the pathogenesis of age-related macular degeneration. Survey of Ophthalmology 2000 45 2 115 134 2-s2.0-0033795036 10.1016/S0039-6257(00) 00140-5
58. Cai J., Nelson K. C., Wu M., Sternberg P. J., Jones D. P., Oxidative damage and protection of the RPE. Progress in Retinal and Eye Research 2000 19 2 205 221 2-s2.0-0033991466 10.1016/S1350-9462(99)00009-9
59. Lee J., Cooke J. P., Nicotine and pathological angiogenesis. Life Sciences 2012 91 1058 1064
60. Wills N. K., Ramanujam V. M. S., Chang J., Kalariya N., Lewis J. R., Weng T.-X., van Kuijk F. J. G. M., Cadmium accumulation in the human retina: effects of age, gender, and cellular toxicity. Experimental Eye Research 2008 86 1 41 51 2-s2.0-36749089483 10.1016/j.exer.2007.09.005 (Pubitemid 350212877)
61. Deisinger P. J., Hill T. S., English J. C., Human exposure to naturally occurring hydroquinone. Journal of Toxicology and Environmental Health 1996 47 1 31 46 2-s2.0-0030068243
62. DeCaprio A. P., The toxicology of hydroquinone-relevance to occupational and environmental exposure. Critical Reviews in Toxicology 1999 29 3 283 330 2-s2.0-0033022871 10.1080/10408449991349221 (Pubitemid 29262956)
63. Holtkamp G. M., De Vos A. F., Peek R., Kijlsta A., Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF- β 2) by human retinal pigment epithelial cells. Clinical and Experimental Immunology 1999 118 1 35 40 2-s2.0-0032835569 10.1046/j.1365-2249.1999.01016.x (Pubitemid 29479781)
64. Uetama T., Ohno-Matsui K., Nakahama K.-I., Morita I., Mochizuki M., Phenotypic change regulates monocyte chemoattractant protein-1 (MCP-1) gene expression in human retinal pigment epithelial cells. Journal of Cellular Physiology 2003 197 1 77 85 2-s2.0-0141483546 10.1002/jcp.10342 (Pubitemid 37486229)
65. Pons M., Marin-Castaño M. E., Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo. PLoS ONE 2011 6 2 2-s2.0-79952230345 10.1371/journal.pone. 0016722 e16722
66. Espinosa-Heidmann D. G., Suner I. J., Catanuto P., Hernandez E. P., Marin-Castano M. E., Cousins S. W., Cigarette smoke-related oxidants and the development of sub-RPE deposits in an experimental animal model of dry AMD. Investigative Ophthalmology and Visual Science 2006 47 2 729 737 2-s2.0-33644859329 10.1167/iovs.05-0719 (Pubitemid 46768404)
67. Bhutto I. A., McLeod D. S., Hasegawa T., Kim S. Y., Merges C., Tong P., Lutty G. A., Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Experimental Eye Research 2006 82 1 99 110 2-s2.0-30344447284 10.1016/j.exer.2005.05.007 (Pubitemid 43063401)
68. Martey C. A., Pollock S. J., Turner C. K., O'Reilly K. M. A., Baglole C. J., Phipps R. P., Sime P. J., Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. American Journal of Physiology: Lung Cellular and Molecular Physiology 2004 287 5 L981 L991 2-s2.0-6344263598 10.1152/ajplung.00239.2003 (Pubitemid 39391028)
69. Shapiro S. D., Smoke gets in your cells. American Journal of Respiratory Cell and Molecular Biology 2004 31 5 481 482 2-s2.0-7744244729 10.1165/rcmb.F285 (Pubitemid 39463395)
70. Baglole C. J., Sime P. J., Phipps R. P., Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. American Journal of Physiology: Lung Cellular and Molecular Physiology 2008 295 4 L624 L636 2-s2.0-56149106105 10.1152/ajplung.90215.2008
71. Bertram K. M., Baglole C. J., Phipps R. P., Libby R. T., Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. American Journal of Physiology: Cell Physiology 2009 297 5 C1200 C1210 2-s2.0-70449644673 10.1152/ajpcell.00126.2009
72. Yu A. L., Birke K., Burger J., Welge-Lussen U., Biological effects of cigarette smoke in cultured human retinal pigment epithelial cells. PLoS ONE 2012 7 48501
73. Yu A. L., Fuchshofer R., Kook D., Kampik A., Bloemendal H., Welge-Lüssen U., Subtoxic oxidative stress induces senescence in retinal pigment epithelial cells via TGF- β release. Investigative Ophthalmology and Visual Science 2009 50 2 926 935 2-s2.0-59449099708 10.1167/iovs.07-1003
74. Mishima K., Handa J. T., Aotaki-Keen A., Lutty G. A., Morse L. S., Hjelmeland L. M., Senescence-associated β -galactosidase histochemistry for the primate eye. Investigative Ophthalmology and Visual Science 1999 40 7 1590 1593 2-s2.0-0032978077 (Pubitemid 29252351)
75. Dumont P., Burton M., Chen Q. M., Gonos E. S., Frippiat C., Mazarati J.-B., Eliaers F., Remacle J., Toussaint O., Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast. Free Radical Biology and Medicine 2000 28 3 361 373 2-s2.0-0033963144 10.1016/S0891-5849(99)00249-X (Pubitemid 30110651)
76. Toussaint O., Medrano E. E., Von Zglinicki T., Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of human diploid fibroblasts and melanocytes. Experimental Gerontology 2000 35 8 927 945 2-s2.0-0033732110 10.1016/S0531-5565(00)00180-7
77. Katz M. L., Robison W. G. Jr., What is lipofuscin? Defining characteristics and differentiation from other autofluorescent lysosomal storage bodies. Archives of Gerontology and Geriatrics 2002 34 3 169 184 2-s2.0-0036124957 10.1016/S0167-4943(02)00005-5 (Pubitemid 34224160)
78. Sparrow J. R., Boulton M., RPE lipofuscin and its role in retinal pathobiology. Experimental Eye Research 2005 80 5 595 606 2-s2.0-18044366931 10.1016/j.exer.2005.01.007 (Pubitemid 40602960)
79. Jia L., Liu Z., Sun L., Miller S. S., Ames B. N., Cotman C. W., Liu J., Acrolein, a toxicant in cigarette smoke, causes oxidative damage and mitochondrial dysfunction in RPE cells: protection by (R)- α -lipoic acid. Investigative Ophthalmology and Visual Science 2007 48 1 339 348 2-s2.0-33846923178 10.1167/iovs.06-0248 (Pubitemid 47251422)
80. Liu Z., Sun L., Zhu L., Jia X., Li X., Jia H., Wang Y., Weber P., Long J., Liu J., Hydroxytyrosol protects retinal pigment epithelial cells from acrolein-induced oxidative stress and mitochondrial dysfunction. Journal of Neurochemistry 2007 103 6 2690 2700 2-s2.0-40949095179
81. Conney A. H., Induction of microsomal enzymes for foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G.H.A. Clowes Memorial Lecture. Cancer Research 1982 42 12 4875 4917 2-s2.0-0020431144 (Pubitemid 13223122)
82. Patton W. P., Routledge M. N., Jones G. D., Lewis S. E. M., Archer D. B., Davies R. J. H., Chakravarthy U., Retinal pigment epithelial cell DNA is damaged by exposure to benzo[a]pyrene, a constituent of cigarette smoke. Experimental Eye Research 2002 74 4 513 522 2-s2.0-0036315408 10.1006/exer.2001.1160 (Pubitemid 34757029)
83. Sharma A., Neekhra A., Gramajo A. L., Patil J., Chwa M., Kuppermann B. D., Kenney M. C., Effects of Benzo(e)Pyrene, a toxic component of cigarette smoke, on human retinal pigment epithelial cells in vitro. Investigative Ophthalmology and Visual Science 2008 49 11 5111 5117 2-s2.0-56149118636 10.1167/iovs.08-2060
84. Dunn K. C., Aotaki-Keen A. E., Putkey F. R., Hjelmeland L. M., ARPE-19, a human retinal pigment epithelial cell line with differentiated properties. Experimental Eye Research 1996 62 2 155 169 2-s2.0-0029872876 10.1006/exer.1996.0020 (Pubitemid 26140102)
85. Sharma A., Patil J. A., Gramajo A. L., Seigel G. M., Kuppermann B. D., Kenney C. M., Effects of hydroquinone on retinal and vascular cells in vitro. Indian Journal of Ophthalmology 2012 60 189 193
86. Wang L., Clark M. E., Crossman D. K., Kojima K., Messinger J. D., Mobley J. A., Curcio C. A., Abundant lipid and protein components of drusen. PLoS ONE 2010 5 4 2-s2.0-77956402099 10.1371/journal.pone.0010329 e10329
87. Fujihara M., Nagai N., Sussan T. E., Biswal S., Handa J. T., Chronic cigarette smoke causes oxidative damage and apoptosis to retinal pigmented epithelial cells in mice. PLoS ONE 2008 3 9 2-s2.0-52349098746 10.1371/journal.pone.0003119 e3119
88. Spraul C. W., Lang G. E., Grossniklaus H. E., Morphometric analysis of the choroid, Bruch's membrane, and retinal pigment epithelium in eyes with age-related macular degeneration. Investigative Ophthalmology and Visual Science 1996 37 13 2724 2735 2-s2.0-0030471907 (Pubitemid 27026558)
89. Ross R. J., Verma V., Rosenberg K. I., Chan C. C., Tuo J., Genetic markers and biomarkers for age-related macular degeneration. Expert Review of Ophthalmology 2007 2 443 457
90. Kim T. W., Kang J. W., Ahn J., Proteomic analysis of the aqueous humor in age-related macular degeneration (AMD) patients. Journal of Proteome Research 11 8 4034 4043
91. Yao J., Liu X., Yang Q., Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration. Proteomics 2013 10.1002/prca.201200012
92. Seddon J. M., Gensler G., Milton R. C., Klein M. L., Rifai N., Association between C-reactive protein and age-related macular degeneration. Journal of the American Medical Association 2004 291 6 704 710 2-s2.0-1442314663 10.1001/jama.291.6.704 (Pubitemid 38543790)
93. Seddon J. M., George S., Rosner B., Rifai N., Progression of age-related macular degeneration: prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Archives of Ophthalmology 2005 123 6 774 782 2-s2.0-20644467790 10.1001/archopht.123.6.774 (Pubitemid 41056598)
94. Gibson J., Hakobyan S., Cree A. J., Collins A., Harris C. L., Ennis S., Morgan B. P., Lotery A. J., Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology 2012 217 2 251 255 2-s2.0-84855275016 10.1016/j.imbio.2011.07.015
95. Ozguner F., Koyu A., Cesur G., Active smoking causes oxidative stress and decreases blood melatonin levels. Toxicology and Industrial Health 2005 21 1-2 21 26 2-s2.0-20644459927 10.1191/0748233705th211oa (Pubitemid 40835711)
96. Jia L., Dong Y., Yang H., Pan X., Fan R., Zhai L., Serum superoxide dismutase and malondialdehyde levels in a group of Chinese patients with age-related macular degeneration. Aging 2011 23 4 264 267 2-s2.0-84855446179
97. Shen X., Jia L. H., Zhao P., Fan R., Pan X. Y., Yang H. M., Liu L., Changes in blood oxidative and antioxidant parameters in a group of Chinese patients with age-related macular degeneration. Journal of Nutrition, Health and Aging 2012 16 201 204 2-s2.0-81555235619 10.1007/s12603-011-0350-8
98. Yanbaeva D. G., Dentener M. A., Creutzberg E. C., Wesseling G., Wouters E. F. M., Systemic effects of smoking. Chest 2007 131 5 1557 1566 2-s2.0-34248592200 10.1378/chest.06-2179 (Pubitemid 46762366)
99. Heinonen O. P., Albanes D., The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. New England Journal of Medicine 1994 330 15 1029 1035 2-s2.0-0010607277 10.1056/ NEJM199404143301501 (Pubitemid 24106559)
100. Omenn G. S., Goodman G. E., Thornquist M. D., Balmes J., Cullen M. R., Glass A., Keogh J. P., Meyskens F. L. Jr., Valanis B., Williams J. H. Jr., Barnhart S., Hammar S., Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. New England Journal of Medicine 1996 334 18 1150 1155 2-s2.0-9244262406 10.1056/NEJM199605023341802 (Pubitemid 26137973)
101. Age-Related Eye Disease Study Research Group, A randomized, placebo-controlled, clinical trial of highdose supplementationwith vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2001 119 1417 1436
102. Age-Related Eye Disease Study 2 Research Group, Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. Journal of the American Medical Association 2013 309 2005 2015
103. Lee S., Song S. J., Yu H. G., Current smoking is associated with a poor visual acuity improvement after intravitreal ranibizumab therapy in patients with exudative age-related macular degeneration. Journal of Korean Medical Science 2013 28 769 774
104. McKibbin M., Ali M., Bansal S., Baxter P. D., West K., Williams G., Cassidy F., Inglehearn C. F., CFH, VEGF and HTRA1 promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. British Journal of Ophthalmology 2012 96 2 208 212 2-s2.0-84856059368 10.1136/bjo.2010.193680
105. Hughes A. E., Orr N., Patterson C., Esfandiary H., Hogg R., McConnell V., Silvestri G., Chakravarthy U., Neovascular age-related macular degeneration risk based on CFH, LOC387715/HTRA1, and smoking. PLoS Medicine 2007 4, article e355 2-s2.0-38049086708 10.1371/journal.pmed.0040355
106. Rennie C. A., Stinge A., King E. A., Sothirachagan S., Osmond C., Lotery A. J., Can genetic risk information for age-related macular degeneration influence motivation to stop smoking A pilot study. Eye 2012 26 1 109 118 2-s2.0-84855821917 10.1038/eye.2011.256
107. Priya R. R., Chew E. Y., Swaroop A., Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management. Ophthalmology 2012 119 2526 2536
108. Stone E. M., Aldave A. J., Drack A. V., Maccumber M. W., Sheffield V. C., Traboulsi E., Weleber R. G., Recommendations for genetic testing of inherited eye diseases. Report of the American Academy of Ophthalmology Task Force on Genetic Testing. Ophthalmology 2012 119 2408 2410